Join our mailing list
Get exclusive deals and learn about new products!
Reliable shipping
Flexible returns
Due to continuous technical developments and new insights into the high complexity of neurological diseases, there is an increasing need for the application of proteomic technologies which can yield potential biomarker readouts for improved clinical management as well as for the development of new drugs by struggling pharmaceutical companies. This book describes the step-by-step use of proteomic methods such as two-dimensional gel electrophoresis, multiplex immunoassay, liquid chromatography mass spectrometry (LC-MS) and selective reaction monitoring MS, to increase our understanding of these diseases, with the ultimate aim of improving patient care.
Published by: Springer
Publication Date: 2017-04-04
Format: Hardcover
ISBN-13: 9783319524788
DOI: 10.1007/978-3-319-52479-5
Dimensions: 235cm x155cm
Pages: 370